Efficacy and Safety of Quetiapine Fumarate (SEROQUEL®) in the Treatment of Alcohol Dependency in Patients With Bipolar Disorder

This study has been completed.

Study NCT00114686 Information provided by AstraZeneca

First Received: June 16, 2005 Last Updated: March 24, 2009 History of Changes

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been completed.
Study Completion Date:	April 2007
Estimated Primary Completion Date:	No date given